{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T04:24:57Z","timestamp":1772598297955,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00432-020-03222-w","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T18:06:57Z","timestamp":1587665217000},"page":"2161-2171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis"],"prefix":"10.1007","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-0681","authenticated-orcid":false,"given":"Bolin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-9086","authenticated-orcid":false,"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"key":"3222_CR1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10620-005-2698-2","volume":"50","author":"H Ashktorab","year":"2005","unstructured":"Ashktorab H, Dawkins FW, Mohamed R, Larbi D, Smoot DT (2005) Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells. Dig Dis Sci 50:1025\u20131032. https:\/\/doi.org\/10.1007\/s10620-005-2698-2","journal-title":"Dig Dis Sci"},{"key":"3222_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. NEJM 348:891\u2013899","journal-title":"NEJM"},{"key":"3222_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/bjc.2012.101","volume":"106","author":"E Bastiaannet","year":"2012","unstructured":"Bastiaannet E et al (2012) Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer 106:1564\u20131570. https:\/\/doi.org\/10.1038\/bjc.2012.101","journal-title":"Br J Cancer"},{"key":"3222_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2009.1112","volume":"302","author":"AT Chan","year":"2009","unstructured":"Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302:649\u2013658. https:\/\/doi.org\/10.1001\/jama.2009.1112","journal-title":"JAMA"},{"key":"3222_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","volume":"107","author":"CE Eberhart","year":"1994","unstructured":"Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183\u20131188. https:\/\/doi.org\/10.1016\/0016-5085(94)90246-1","journal-title":"Gastroenterology"},{"key":"3222_CR6","doi-asserted-by":"publisher","first-page":"16937","DOI":"10.1038\/s41598-019-53276-1","volume":"9","author":"J Fu","year":"2019","unstructured":"Fu J, Xu Y, Yang Y, Liu Y, Ma L, Zhang Y (2019) Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-kappaB activation. Sci Rep 9:16937. https:\/\/doi.org\/10.1038\/s41598-019-53276-1","journal-title":"Sci Rep"},{"key":"3222_CR7","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1200\/jco.2005.23.16_suppl.3530","volume":"23","author":"C Fuchs","year":"2005","unstructured":"Fuchs C, Meyerhardt JA, Heseltine DL, Niedzwiecki D, Mayer RJ (2005) Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from intergroup trial CALGB 89803. J Clin Oncol 23:3530\u20133530","journal-title":"J Clin Oncol"},{"key":"3222_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/bjc.2017.175","volume":"117","author":"KJ Gash","year":"2017","unstructured":"Gash KJ, Chambers AC, Cotton DE, Williams AC, Thomas MG (2017) Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy. Br J Cancer 117:210\u2013219. https:\/\/doi.org\/10.1038\/bjc.2017.175","journal-title":"Br J Cancer"},{"key":"3222_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay LJ, Felding-Habermann B (2011) Contribution of platelets to tumour metastasis. Nat Rev Cancer 11:123\u2013134. https:\/\/doi.org\/10.1038\/nrc3004","journal-title":"Nat Rev Cancer"},{"key":"3222_CR10","doi-asserted-by":"publisher","first-page":"151452","DOI":"10.1016\/j.anndiagpath.2019.151452","volume":"45","author":"I Gonzalez","year":"2019","unstructured":"Gonzalez I, Bauer PS, Chapman WC Jr, Alipour Z, Rais R, Liu J, Chatterjee D (2019) Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma. Ann Diagn Pathol 45:151452. https:\/\/doi.org\/10.1016\/j.anndiagpath.2019.151452","journal-title":"Ann Diagn Pathol"},{"key":"3222_CR11","first-page":"106","volume":"15","author":"X Guo","year":"2018","unstructured":"Guo X, Ni B, Chen R, Zhu Z, Lin L (2018) Clinical study of aspirin as adjuvant agent during neoadjuvant chemradiotherapy for rectal cancer Lab. Med Clin 15:106\u2013109","journal-title":"Med Clin"},{"key":"3222_CR12","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1200\/JCO.2016.70.7547","volume":"35","author":"T Hamada","year":"2017","unstructured":"Hamada T et al (2017) Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status. J Clin Oncol 35:1836\u20131844","journal-title":"J Clin Oncol"},{"key":"3222_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/ajco.12468","volume":"12","author":"C Hardie","year":"2016","unstructured":"Hardie C, Jung Y, Jameson M (2016) Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer. Asia Pac J Clin Oncol 12:167\u2013173. https:\/\/doi.org\/10.1111\/ajco.12468","journal-title":"Asia Pac J Clin Oncol"},{"key":"3222_CR14","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/sim.4088","volume":"30","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Whitehead A, Simmonds M (2011) Sequential methods for random-effects meta-analysis. Stat Med 30:903\u2013921. https:\/\/doi.org\/10.1002\/sim.4088","journal-title":"Stat Med"},{"key":"3222_CR15","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1200\/JCO.2017.72.3569","volume":"35","author":"X Hua","year":"2017","unstructured":"Hua X et al (2017) Timing of aspirin and other nonsteroidal anti-inflammatory drug use among patients with colorectal cancer in relation to tumor markers and survival. J Clin Oncol Off J Am Soc Clin Oncol 35:2806\u20132813","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3222_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jim-2016-000275","volume":"65","author":"U Iqbal","year":"2017","unstructured":"Iqbal U, Yang HC, Jian WS, Yen Y, Li YJ (2017) Does aspirin use reduce the risk for cancer? J Investig Med Off Publ Am Fed Clin Res 65:391\u2013392. https:\/\/doi.org\/10.1136\/jim-2016-000275","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"3222_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.ijrobp.2004.12.033","volume":"62","author":"MS Katz","year":"2005","unstructured":"Katz MS, Minsky BD, Saltz LB, Riedel E, Chessin DB, Guillem JG (2005) Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 62:1363\u20131370. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.12.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3222_CR18","first-page":"4399","volume":"48","author":"GA Kune","year":"1988","unstructured":"Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399\u20134404","journal-title":"Cancer Res"},{"key":"3222_CR19","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1111\/j.1463-1318.2009.02015.x","volume":"12","author":"T Latkauskas","year":"2010","unstructured":"Latkauskas T, Paskauskas S, Dambrauskas Z, Gudaityte J, Saladzinskas S, Tamelis A, Pavalkis D (2010) Preoperative chemoradiation vs radiation alone for stage II and III resectable rectal cancer: a meta-analysis. Colorectal Dis Off J Assoc Coloproctol G B Irel 12:1075\u20131083. https:\/\/doi.org\/10.1111\/j.1463-1318.2009.02015.x","journal-title":"Colorectal Dis Off J Assoc Coloproctol G B Irel"},{"key":"3222_CR20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","volume":"64","author":"P Li","year":"2015","unstructured":"Li P et al (2015) Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis. Gut 64:1419\u20131425. https:\/\/doi.org\/10.1136\/gutjnl-2014-308260","journal-title":"Gut"},{"key":"3222_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","volume":"367","author":"X Liao","year":"2012","unstructured":"Liao X, Lochhead P, Nishihara R, Morikawa T, Ogino S (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367:1596\u20131606","journal-title":"N Engl J Med"},{"key":"3222_CR22","first-page":"988","volume":"30","author":"Y Liu","year":"2014","unstructured":"Liu Y, Gao D, Zhong J, Wan Y, Li X, Jin G, Wang X (2014) Synergistic anti-proliferation effect of aspirin and 5-fluorouracil on colon cancer cells and its mechanism. Chin J Pathophysiol 30:988\u2013993","journal-title":"Chin J Pathophysiol"},{"key":"3222_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/cncr.30600","volume":"123","author":"EB Ludmir","year":"2017","unstructured":"Ludmir EB, Palta M, Willett CG, Czito BG (2017) Total neoadjuvant therapy for rectal cancer: an emerging option. Cancer 123:1497\u20131506. https:\/\/doi.org\/10.1002\/cncr.30600","journal-title":"Cancer"},{"key":"3222_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/bjs.8702","volume":"99","author":"ST Martin","year":"2012","unstructured":"Martin ST, Heneghan HM, Winter DC (2012) Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 99:918\u2013928. https:\/\/doi.org\/10.1002\/bjs.8702","journal-title":"Br J Surg"},{"key":"3222_CR25","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1002\/cncr.30079","volume":"122","author":"ZS Morris","year":"2016","unstructured":"Morris ZS et al (2016) Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Cancer 122:2487\u20132495. https:\/\/doi.org\/10.1002\/cncr.30079","journal-title":"Cancer"},{"key":"3222_CR26","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1001\/jama.2013.6599","volume":"309","author":"R Nishihara","year":"2013","unstructured":"Nishihara R et al (2013) Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA 309:2563\u20132571. https:\/\/doi.org\/10.1001\/jama.2013.6599","journal-title":"JAMA"},{"key":"3222_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/bjc.2015.336","volume":"113","author":"A Restivo","year":"2015","unstructured":"Restivo A, Cocco IM, Casula G, Scintu F, Cabras F, Scartozzi M, Zorcolo L (2015) Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer 113:1133\u20131139. https:\/\/doi.org\/10.1038\/bjc.2015.336","journal-title":"Br J Cancer"},{"key":"3222_CR28","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376:1741\u20131750. https:\/\/doi.org\/10.1016\/S0140-6736(10)61543-7","journal-title":"Lancet"},{"key":"3222_CR29","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol Off J Am Soc Clin Oncol 30:1926\u20131933. https:\/\/doi.org\/10.1200\/JCO.2011.40.1836","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3222_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67:177\u2013193. https:\/\/doi.org\/10.3322\/caac.21395","journal-title":"CA Cancer J Clin"},{"key":"3222_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"3222_CR32","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jamaoncol.2019.0611","volume":"5","author":"M Skelin","year":"2019","unstructured":"Skelin M, Javor E, Lucijanic M (2019) Aspirin use and the risk of cancer. JAMA Oncol 5:912\u2013913. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0611","journal-title":"JAMA Oncol"},{"key":"3222_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.6004\/jnccn.2018.7032","volume":"16","author":"CA Smith","year":"2018","unstructured":"Smith CA, Kachnic LA (2018) Evolving treatment paradigm in the treatment of locally advanced rectal cancer. J Natl Compr Cancer Net JNCCN 16:909\u2013915. https:\/\/doi.org\/10.6004\/jnccn.2018.7032","journal-title":"J Natl Compr Cancer Net JNCCN"},{"key":"3222_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605. https:\/\/doi.org\/10.1007\/s10654-010-9491-z","journal-title":"Eur J Epidemiol"},{"key":"3222_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C (2009) Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 9:86. https:\/\/doi.org\/10.1186\/1471-2288-9-86","journal-title":"BMC Med Res Methodol"},{"key":"3222_CR36","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1038\/bjc.2014.481","volume":"111","author":"XF Ye","year":"2014","unstructured":"Ye XF, Wang J, Shi WT, He J (2014) Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies. Br J Cancer 111:2172\u20132179. https:\/\/doi.org\/10.1038\/bjc.2014.481","journal-title":"Br J Cancer"},{"key":"3222_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/bjs.11171","volume":"106","author":"A Zaborowski","year":"2019","unstructured":"Zaborowski A, Stakelum A, Winter DC (2019) Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer. Br J Surg 106:979\u2013987. https:\/\/doi.org\/10.1002\/bjs.11171","journal-title":"Br J Surg"},{"key":"3222_CR38","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1245\/s10434-011-2209-y","volume":"19","author":"L Zorcolo","year":"2012","unstructured":"Zorcolo L, Rosman AS, Restivo A, Pisano M, Nigri GR, Fancellu A, Melis M (2012) Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 19:2822\u20132832. https:\/\/doi.org\/10.1245\/s10434-011-2209-y","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03222-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03222-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03222-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T23:46:53Z","timestamp":1619135213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03222-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3222"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03222-w","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}